These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11988846)

  • 1. Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy.
    Kragh M; Quistorff B; Horsman MR; Kristjansen PE
    Neoplasia; 2002; 4(3):263-7. PubMed ID: 11988846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of vascular targeting agents with thermal or radiation therapy.
    Horsman MR; Murata R
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1518-23. PubMed ID: 12459380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.
    Murata R; Overgaard J; Horsman MR
    Int J Radiat Biol; 2001 Feb; 77(2):195-204. PubMed ID: 11236926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours.
    Chen G; Horsman MR; Pedersen M; Pang Q; Stødkilde-Jørgensen H
    Acta Oncol; 2008; 47(6):1071-6. PubMed ID: 18770061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
    Breidahl T; Nielsen FU; Stødkilde-Jørgensen H; Maxwell RJ; Horsman MR
    Acta Oncol; 2006; 45(3):306-16. PubMed ID: 16644574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
    Murata R; Siemann DW; Overgaard J; Horsman MR
    Radiother Oncol; 2001 Aug; 60(2):155-61. PubMed ID: 11439210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure.
    Ley CD; Horsman MR; Kristjansen PE
    Neoplasia; 2007 Feb; 9(2):108-12. PubMed ID: 17356706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
    Murata R; Overgaard J; Horsman MR
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1018-24. PubMed ID: 11704326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid.
    Cliffe S; Taylor ML; Rutland M; Baguley BC; Hill RP; Wilson WR
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):373-7. PubMed ID: 8195036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
    Siemann DW; Mercer E; Lepler S; Rojiani AM
    Int J Cancer; 2002 May; 99(1):1-6. PubMed ID: 11948484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS.
    Beauregard DA; Pedley RB; Hill SA; Brindle KM
    NMR Biomed; 2002 Apr; 15(2):99-105. PubMed ID: 11870905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Siemann DW; Overgaard J; Horsman MR
    Radiat Res; 2001 Nov; 156(5 Pt 1):503-9. PubMed ID: 11604063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
    Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
    Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Overgaard J; Horsman MR
    Int J Hyperthermia; 2001; 17(6):508-19. PubMed ID: 11719967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tumor response to the vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid or combretastatin-A4-phosphate by intrinsic susceptibility magnetic resonance imaging.
    McPhail LD; Griffiths JR; Robinson SP
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1238-45. PubMed ID: 17967313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
    Nielsen T; Murata R; Maxwell RJ; Stødkilde-Jørgensen H; Ostergaard L; Horsman MR
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):859-66. PubMed ID: 18164835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of NIRS, laser Doppler flowmetry, photoplethysmography, and pulse oximetry during vascular occlusion challenges.
    Abay TY; Kyriacou PA
    Physiol Meas; 2016 Apr; 37(4):503-14. PubMed ID: 26963349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy.
    Kragh M; Quistorff B; Lund EL; Kristjansen PE
    Neoplasia; 2001; 3(4):324-30. PubMed ID: 11571632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.